Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | EVI2B |
| Upstream (Parents) |
|---|
| (<<) CCL5 → EVI2B |
| (<<) GZMK → EVI2B |
| (<<) TRBC1 → EVI2B |
| (<<) LY96 → EVI2B |
| (<<) SAMSN1 → EVI2B |
| (<<) CD48 → EVI2B |
| Downstream (Children) |
|---|
| EVI2B → TARP (>>) |
| EVI2B → TRAF3IP3 (>>) |
| EVI2B → EEF1A2 (>>) |
| EVI2B → CD1E (>>) |
| EVI2B → P2RY13 (>>) |
| EVI2B → CD69 (>>) |
| EVI2B → PRKCB (>>) |
| EVI2B → P2RY10 (>>) |
| EVI2B → GPR183 (>>) |
| EVI2B → FAM65B (>>) |
| EVI2B → MAPT (>>) |
| EVI2B → ST3GAL2 (>>) |
| EVI2B → STK17B (>>) |
| EVI2B → CD1B (>>) |
| EVI2B → SATB1 (>>) |
| EVI2B → PLA2G7 (>>) |
| EVI2B → BATF3 (>>) |
| EVI2B → WNT2 (>>) |
| EVI2B → OSR2 (>>) |
| EVI2B → LY75 (>>) |
| EVI2B → CLN6 (>>) |
| EVI2B → LYN (>>) |
| EVI2B → HLA-DQB2 (>>) |
| EVI2B → SLC36A1 (>>) |
| EVI2B → FOLR2 (>>) |
| EVI2B → LBR (>>) |
| EVI2B → CD48 (>>) |
| EVI2B → DPYD (>>) |
